I
n the past 40 years, our recognition of cardiac neoplasms has progressed from clinical curiosities described primarily in numerous case reports with diagnosis mainly at autopsy to fairly rapid antemortem diagnosis and frequent curative operative therapy. Diagnosis has been greatly facilitated by 2-dimensional echocardiography and, in select cases, the use of magnetic resonance imaging (MRI) or computed tomography (CT). This article describes a classification of cardiac neoplasms, their location, techniques for diagnosis, and specific benign and malignant neoplasms. It also describes secondary tumors of the heart and conditions frequently mistaken for cardiac neoplasms. It closes with a section on adverse consequences of therapy.
CLASSIFICATION
There is no perfect classification for cardiac neoplasms. As in any organ or tissue, neoplasms involving the heart may be primary or secondary. The primary ones may be benign or malignant, and the secondary or metastatic ones are, by definition, malignant. Metastatic neoplasms are far more frequent than primary neoplasms by a ratio of at least 30 to 1 (1, 2) .
The frequencies of the primary benign and primary malignant tumors vary from report to report, approximately 0.1% to 0.3% in most autopsy series. A list of primary benign neoplasms gathered by investigators at the Armed Forces Institute of Pathology is presented in Table 1 , and primary malignant tumors encountered are listed in Table 2 (3) . The frequencies of the metastatic neoplasms also vary from report to report, but nearly all studies have listed carcinoma of the lung as the most frequently encountered secondary tumor at autopsy, with cancer of the breast, lymphoma, and leukemia as the next leading causes (Table 3 ). The order of frequency of secondary tumors is different, however, if the frequency of each different type of tumor that metastasizes to the heart is determined. For example, Table 4 lists the frequencies of metastases to the heart in 100 cases of each of 20 separate tumors; melanoma has the highest frequency of metastases to the heart, followed by malignant germ cell tumor, leukemia, lymphoma, cancer of the lung, and then the various sarcomas (3). 
LOCATION OF CARDIAC NEOPLASMS
Cardiac neoplasms may involve only the endocardium, only the myocardium, only the epicardium, or any combination of these ( Figure 1 ). By far the most common location of metastatic cardiac neoplasm is the epicardium. Neoplasms limited to parietal pericardium without extension into the epicardium are not considered cardiac neoplasms. The epicardial tumor deposits may be multifocal or single, or they may be extensive and essentially diffuse or nearly so. Likewise, the intramyocardial masses may be focal or multifocal. The most common locations for intramyocardial masses are the left ventricular free wall and the ventricular septum, which are, of course, the portions of the heart with the greatest myocardial mass. The endocardial neoplasms are the intracavitary ones. They may involve a single cardiac cavity or more than one. They may be limited to either the right or left side of the heart, or they may involve both. Intracavitary tumors produce obstruction to inflow into the heart or into a ventricular cavity or outflow from a ventricular cavity. The intracavitary neoplasms are the ones that may partially dislodge and produce either pulmonary or systemic emboli or both. They have the potential of producing the triad of obstruction, embolization, and constitutional symptoms.
TECHNIQUES FOR DIAGNOSING CARDIAC NEOPLASMS Symptoms and physical signs
The signs and symptoms produced by the various cardiac neoplasms are determined primarily by the tumor's location in the heart. Physical examination is rarely diagnostic (4-7).
Electrocardiogram
The electrocardiogram is usually nonspecific (8, 9) , but it could be far more useful than has been appreciated in the past. The problem has been that the electrocardiogram may be recorded when diagnosis is first considered, but subsequently electrocardiograms are not taken very frequently as the disease progresses. One study compared electrocardiographic findings in patients with malignant lymphoma who had cardiac involvement with another group of patients with lymphoma who did not have cardiac involvement (8) . The percentage with abnormal tracings (62%) was similar in the 2 groups. Fewer than half the patients had >1 electrocardiogram during the entire illness. Findings included sinus tachycardia; low voltage; ectopic tachycardia, including atrial fibrillation; atrial flutter; atrial tachycardia; atrial ventricular block, including prolonged PR interval; secondor third-degree block; premature ventricular complexes; right or left axis deviation; right bundle branch block; T-wave abnormalities; and ST-T wave changes, usually of nonspecific nature. The sudden development of some of these electrocardiographic findings in a patient who previously lacked these changes suggests cardiac involvement.
Radiograph
The chest radiograph may be helpful, particularly when an epicardial neoplasm is present (10) . Enlargement or an irregular contour of the cardiac silhouette, mediastinal widening, or a hilar mass may suggest pericardial involvement. Calcium within an intracardiac neoplasm can be seen on occasion by chest radiograph or fluoroscopy. The lung fields may have a paucity of pulmonary markings in patients with large right atrial or right ventricular neoplasms. Patients with neoplasms in the left atrium may have pulmonary changes similar to those in mitral stenosis. Left ventricular neoplasms causing obstruction to left ventricular inflow or outflow may produce similar pulmonary arterial vascular changes.
Echocardiogram
More cardiac tumors today are diagnosed by echocardiography, at least initially, than by any other instrument of precision. Diagnosis of left atrial myxoma has been one of the principal uses of echocardiography since the introduction of the technique (11) (12) (13) (14) (15) . The classic left atrial myxoma is a mobile echogenic mass that is in the body of the left atrium in ventricular systole and passes into the mitral orifice in ventricular diastole. Occasionally, an echocardiogram will detect a left atrial myxoma that is small or not close to the mitral orifice, and it is therefore clinically silent.
Although it is usually possible to detect intracardiac tumors with transthoracic echocardiography, the transesophageal examination produces spectacular images and makes diagnosis, particularly of atrial masses, relatively easy (16, 17) . The transesophageal examination not only offers a higher sensitivity for detecting left atrial tumors, for example, but also permits a clearer picture of the attachment or stalk of the tumor and more precise characterization of the size, shape, and location of the mass. A major advantage of echocardiography is its ability to provide serial studies. Thus, this technique may be used to monitor progressive increase in size of a neoplasm or detect recurrence once the initial tumor is excised.
The echocardiogram has been useful in detecting intracardiac tumors other than myxomas, including rhabdomyomas and rhabdomyosarcomas, neoplasms that occur primarily in infants and are usually located in the ventricles. The echocardiogram is also helpful in detecting metastases to the heart. This is particularly true in neoplasms that migrate up the inferior vena cava into the right side of the heart, such as renal cell carcinoma or adrenal cell carcinoma. Echocardiography, particularly transesophageal, has been extremely helpful in detecting mediastinal or extracardiac masses, which may compress the cardiac structure.
Computed tomogram
CT is useful in diagnosing cardiac tumors (18, 19) ; it may be especially useful in defining the degree of intramyocardial extension or the lack thereof and determining whether the tumor is present in adjacent extracardiac structures. Ultrafast CT appears to be particularly well suited for assessing intracardiac masses.
Magnetic resonance imaging
MRI appears to be of greater value than CT in delineating cardiac tumors (20) . It may be able to depict the size, shape, and surface characteristics of the tumor more clearly than CT. This technique also can provide information regarding tissue composition that can help to differentiate neoplasms from thrombi.
Angiogram
A cardiac catheterization and selective angiography are no longer necessary in all patients with cardiac neoplasms because adequate preoperative information can usually be obtained by echocardiography, CT, or MRI. For cases in which the latter 3 techniques have not fully defined the location and attachment of the neoplasm, in which all 4 chambers of the heart have not been well delineated, or in which another type of cardiac condition is suspected (such as coronary arterial narrowing), cardiac catheterization with angiography might be necessary.
Angiography in patients with cardiac neoplasms is particularly useful in detecting compression or displacement of cardiac cavities or large masses and determining the magnitude of the intracavitary filling defects. The most frequent angiographic findings are intracavitary filling defects, which may be fixed or mobile, lobulated or smooth, and attached over a broad base or by a narrow stalk. Coronary angiography is sometimes helpful in visualizing the vascular supply of the neoplasm and the relation of the neoplasm to the coronary arteries. The vascular pattern is not helpful, however, in differentiating benign from malignant tumors.
In contrast to the other diagnostic techniques, cardiac catheterization can be a bit risky in patients with intracardiac neoplasms, because the catheter may dislodge a fragment of the tumor with resulting embolus. Thus, the noninvasive techniques are preferred to cardiac catheterization in a patient suspected of having an intracardiac mass. The transseptal approach to the left atrium is not advised if a left atrial tumor is suspected, because the stalk of the left atrial myxoma is usually attached to the fossa ovale membrane, where the transseptal catheter courses.
SPECIFIC BENIGN PRIMARY CARDIAC NEOPLASMS Myxoma
Myxomas are by far the most common type of primary cardiac tumor; 75% of them are located in the left atrial cavity (Figures 2 and 3) , about 23% in the right atrial cavity (Figure 4 ), and about 2% in a ventricular cavity (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (Figure 5) . On rare occasions, the tumor is present in >1 cavity. Generally, when located in the left atrium, the neoplasm produces symptoms when it reaches about 7 cm in size. Neoplasms in the right atrium that produce symptoms are usually about twice as large and sometimes several times larger. The cell of origin of the myxoma is still unclear (22, (34) (35) (36) .
How fast atrial myxomas grow has never been clarified. An attempt to answer this question was provided by a study that examined the size of recurrent myxomas and divided their mass in grams by the interval between the first and second operations (37) . It was estimated that recurrent left atrial myxomas grow an average of 0.15 cm per month or 1.8 cm per year, or an average of 1.2 g per month or 14 g per year. Whatever the exact growth rate may be, both recurrent and initial left atrial myxomas appear to grow rather rapidly (38, 39) .
Morphologic diagnosis of myxoma is readily made by gross inspection, and its appearance is clearly different from that of thrombi. The surface is smooth but irregular, shiny, and usually multicolored. Although there are exceptions (29) (30) (31) (32) (40) (41) (42) (43) , the tumor is nearly always attached to the atrial septum if it is in the left atrium, and the stalk is most commonly much smaller than the maximal diameter of the mass. On occasion, the site of attachment to the atrial septum is broad. The mean age of patients with sporadic myxoma is 56 years, and at least 75% are women. During the past 10 years at Baylor University Medical Center, at least 15 left atrial myxomas have been excised; 14 were in women.
Familial cardiac myxomas constitute approximately 10% of all myxomas, and they appear to have an autosomal-dominant transmission (44) . These occur in younger patients (mean age, 25 years) and have less female gender predominance. The myxomas in the familial syndrome are much more liable to be multiple (50% of the time) and to have a ventricular cavity location (13% compared with <1% in the nonfamilial or sporadic myxomas). Patients with familial myxoma typically have exterior facial freckling; they have noncardiac myxomas (breast or skin) and also endocrine neoplasms. Both the NAME (nevi, atrial myxoma, neurofibromas, ephelides) and the LAMB (lentigines, atrial myxoma, and balloon nevi) syndromes are associated with the familial variety of cardiac myxoma. Chromosomal abnormalities for atrial myxoma have been described on chromosome 2 (Carney's) and chromosome 12 (Ki-ras genes).
Myxomas probably present the most varied clinical picture of all primary cardiac neoplasms (4-6, 23, 25, 26, 45) . Several major syndromes have been observed, including presentation with signs of emboli, obstruction of blood flow, and various constitutional syndromes. Fragments of tumor located in the right side of the heart may embolize to the lungs, and those in the left side of the heart, of course, to various systemic organs. Diagnosis may be made, on occasion, by finding typical myxomatous endothelial-like cellswhich are elongated and spindle shaped with round or oval nuclei and prominent nucleoli-in surgically removed emboli.
Obstruction of blood flow may occur at the orifice of any valve, most commonly, of course, the mitral valve. Interference with flow through the mitral orifice may mimic signs of mitral stenosis, including signs of pulmonary congestion, diastolic apical rumble, opening snap, and accentuated first heart sounds. A murmur of mitral regurgitation may also be present as a result of chronic damage to the valve leaflets or of interference with proper closure of the valve by tumor. Differentiation between a left atrial tumor and primary mitral stenosis is suggested by the influence of position on symptoms and on the intensity of the precordial murmurs and the opening snap.
The constitutional symptoms associated with atrial myxomas include fever, weight loss, Raynaud's phenomenon, digital clubbing, anemia, elevated erythrocyte sedimentation rate, elevated leukocyte count, decreased platelet count, positive seroreactive protein, and abnormal serum proteins (usually increased gamma globulins). These constitutional symptoms may mimic infective endocarditis, collagen vascular disease, or occult malignancy. A myxoma also may become infected (46) .
The proper treatment of myxoma in any cavity of the heart is operative resection, because no medicine is known to shrink myxomas or to prevent their continued growth (21, 27, 33) . Some surgeons advise a biatrial approach for full visualization of both sides of the heart and then complete removal of a left or right atrial myxoma, excising the full thickness of the atrial septum if the neoplasm is attached to the region of the fossa ovalis. If a large portion of the atrial septum is removed, a patch must be used to close the defect. Because fragmentation and embolization of the tumor is an ever-present threat, vigorous palpa- tion and other manipulations of the heart should be avoided until cardiopulmonary bypass is initiated. Most surgeons induce ventricular standstill with cardioplegia solution before manipulating the heart to reduce the possibility of fragmentation of portions of the tumor. Left atrial myxomas have been removed successfully during pregnancy. On occasion, an atrioventricular valve has been so traumatized by the tumor's prolapsing through it during ventricular diastole that valve excision and replacement are necessary. Fortunately, recurrences of atrial myxomas are rare, and if they do recur, the recurrence usually occurs within 4 years of surgical resection of the initial tumor (38, 39) .
or MRI. Prenatal detection of intracardiac rhabdomyoma by intrauterine echocardiography has been reported. The occurrence of >1 tumor does not prevent operative intervention. On rare occasions, these tumors have produced ventricular tachycardia in infants, and this arrhythmia has disappeared following successful operative removal.
Fibroma
Fibromas usually appear within a ventricular wall (i.e., intramural) (3, 52) (Figure 6 ). Most also occur in infants and children. Calcific deposits may be present within the neoplasm. Sudden death has occurred in about a third of the patients, presumably the result of a conduction defect, arrhythmia, or obstruction to outflow from a ventricle. Left axis deviation has been seen on electrocardiogram. Total or partial resection of the neoplasm may relieve obstruction with an excellent probability of long-term survival.
Rhabdomyoma
The most common cardiac neoplasm in infants and children is rhabdomyoma (47) . There is some question whether this particular tumor is a true neoplasm or a hamartoma. These neoplasms are usually multiple, most often involve the ventricular myocardium, and project into the cavity or move freely as a pedunculated mass (48) (49) (50) . Associated tuberous sclerosis is present in about one third of the patients. The diagnosis is suggested by the presence of yellow-brown angiofibromas ("adenoma sebaceum") on the face, subungual fibromas around the fingernails, café au lait spots, and subcutaneous nodules. Presenting symptoms may be caused by obstruction to inflow to or outflow from the ventricles, arrhythmias, atrioventricular block, or pericardial effusion; at times the "presenting symptom" is sudden death (51) . These neoplasms may mimic pulmonic valve stenosis and produce hypoxic spells resembling those seen in tetralogy of Fallot. They are usually readily diagnosed by echocardiography, angiography, 
Lipoma
Lipomas involving the heart may be extremely small and represent incidental necropsy findings, or they may be massive (53) (54) (55) (56) . The largest cardiac neoplasm ever reported apparently was an intrapericardial lipoma. They may be mistaken for pericardial cysts, cause pericardial effusion, or be asymptomatic and suggested by a widened mediastinum on chest radiograph. Intramyocardial lipomas are encapsulated and usually small. Lipomas also have been located on cardiac valves, where they may simulate vegetations or myxomas (55) . MRI permits preoperative identification of these fatty tumors.
Hemangioma
Hemangiomas are best diagnosed by coronary angiography, which yields a characteristic "tumor blush." Spontaneous resolution without treatment has been reported. Total excision is possible only in some cases (Figure 7 ).
SPECIFIC MALIGNANT PRIMARY CARDIAC NEOPLASMS Angiosarcoma
Nearly all primary malignant cardiac neoplasms are sarcomas, and the most frequent one is angiosarcoma (57) (58) (59) (60) (61) (62) , which characteristically originates from the right atrium or from the epicardium of the right atrium. The large quantity of vascular channels within these tumors and the subsequent large quantity of blood flowing through them may produce a continuous precordial murmur. About 25% of all angiosarcomas are, at least in part, intracavitary with valvular obstruction and cause right-sided heart failure and pericardial tamponade with a hemorrhagic-type fluid. The course is rapid with widespread metastases, and operative intervention is usually unsuccessful. a c b Figure 10 . Primary cardiac histiocytic lymphoma. This 64-year-old woman had had evidence of congestive heart failure for 7 months. The cause of the heart failure was not apparent until necropsy. The wall of the left atrium was massively thickened by the neoplasm. Reprinted with permission from Roberts CS, Gottdiener JS, Roberts WC. Clinically undetected cardiac lymphoma causing congestive heart failure. Am Heart J 1990; 120:1239-1242.
Rhabdomyosarcoma
Rhabdomyosarcoma is the second most frequent primary sarcoma of the heart, and, like angiosarcoma, it is most common in males (63) (64) (65) . In contrast to angiosarcoma, however, this neoplasm has no predilection for a specific cardiac chamber. Indeed, the neoplasm may be in all 4 cardiac chambers, or at least in >1, and obstruction may occur in ≥1 valve orifice. Again, prognosis is poor, survival is short, and operative intervention is usually futile.
Miscellaneous
Fibrosarcoma, liposarcoma, primary malignant lymphoma, and occasional sarcomas of other cell types constitute the remaining but infrequent primary malignant coronary neoplasms (66-69) (Figures 8-10) . All of these neoplasms may obstruct valvular orifices, obliterate chambers, obstruct arteries exiting the heart (Figure 11) , and produce peripheral emboli (70) . Hypertrophic cardiomyopathy has been suggested by heavy tumorous infiltrations of the ventricular septum (71) .
METASTATIC NEOPLASMS TO THE HEART
Metastatic or secondary tumors of the heart with a primary tumor in another body organ or tissue are far more frequent than primary tumors of the heart (72) (Figure 12 ). The secondary tumors are far more commonly carcinomas than sarcomas simply because carcinomas are far more common. The diagnosis can be suspected whenever cardiac manifestations occur in a patient diagnosed as having a primary tumor in an organ or tissue other than the heart. The development of cardiac enlargement, tachycardia, arrhythmias, or heart failure in the presence of a neoplasm elsewhere in the body is highly suggestive of cardiac metastases. Only rarely are metastases limited to the heart. Thus, the presence of a metastatic tumor in the heart usually indicates widespread metastases in a number of body organs. On rare occasions, cardiac involvement may be the first or only expression of a noncardiac primary neoplasm. The most common sign is tamponade (73) . Direct invasion of the heart via the vena cava or pulmonary veins may lead to obstruction of an atrioventricular valve; it may also lead to pulmonary or systemic emboli or both (74) (75) (76) .
Carcinoma of the lung and carcinoma of the breast tend to invade the parietal pericardium and then the visceral pericardium, leading to myocardial constriction and/or pericardial effusion (Figure 13 ). Another presentation of lung cancer is invasion of the pulmonary veins within the lung, with spread of the cancer within the lumen of the pulmonary veins into the left atrium. From there, the cancer can continue into the mitral orifice, sometimes causing obstruction (77, 78) (Figure 14) . Cancer in mediastinal lymph nodes also may obstruct pulmonary arteries ( Figure  15 ). In addition, lung cancer metastases in the adrenal gland may extend into the inferior vena cava and then into the right side of the heart (Figure 16 ), just as primary adrenal gland or renal cancer may (79) . Cancer of the lung or breast surrounding the main right or left pulmonary artery can lead to pulmonary arterial obstruction (80) . Carcinoma of the lung may also invade the myocardium from the endocardial side only (Figure 17) .
Of all neoplasms, melanoma has the highest frequency of metastases to the heart per 100 cases (81, 82). The metastases Figure 11 . Primary sarcoma of the pulmonary trunk. This 34-year-old woman was well until 20 days before operative excision of the tumor, when she suddenly experienced severe substernal chest pain with radiation to both arms, associated with dyspnea and nausea, while climbing stairs. A minute or so later she fainted; she awoke about 15 minutes later lying on the floor in a pool of urine. Shortly thereafter she was hospitalized. She appeared healthy. A grade 3/6 systolic, ejection-type precordial murmur, loudest in the pulmonic area, was heard. The lungs were clear. The electrocardiogram was normal. Chest radiograph showed enlargement of the "pulmonary segment." The following pressures in mm Hg were recorded: intrapulmonary pulmonary artery, 20/10; pulmonary trunk, 60/25; right ventricle, 60/18; right atrial mean, 7; pulmonary arterial wedge mean, 11; and aorta, 100/60. (a) Angiography with injection into the right ventricular cavity disclosed large filling defects in the pulmonary trunk and in both right main and left main pulmonary arteries with total lack of filling of arteries to the lower half of the left lung and markedly diminished filling of those to the upper left lung. (b) At thoracotomy, the large tumor completely filled the pulmonary trunk (PT) and main right (MRPA) and left (MLPA) pulmonary arteries, and it was excised. The tumor was attached to the pulmonary trunk over a large base. Histologically, the tumor was an undifferentiated sarcoma. Although the early postoperative course was unremarkable and the pulmonary arterial and right ventricular pressures returned to normal, repeat right ventricular angiogram 7 months postoperatively disclosed a filling defect in the pulmonary trunk. She then underwent resection of the pulmonary trunk containing the sarcoma recurrence and replacement with a graft. Reprinted from Shmookler BM, Marsh HB, Roberts WC. Primary sarcoma of the pulmonary trunk and/or right or left main pulmonary artery-a rare cause of obstruction to right ventricular outflow. Report on two patients and analysis of 35 may be anywhere in the heart; usually melanotic metastases invade the walls of all 4 cardiac chambers and also the epicardium and endocardium (Figures 18  and 19 ). The cancers in these patients are in so many body organs that the presence of the neoplasm in the heart is almost incidental. Resection of an intracardiac melanoma has been accomplished (83) .
Leukemia commonly invades the heart (84). In the days before platelet transfusions, extensive hemorrhages into the myocardial walls and into the endocardium and epicardium were commonly found in patients with fatal leukemia of various types. Histologically, leukemic infiltration between myocardial cells is quite common, and sometimes gross deposits of leukemic cells are visible within the heart ( Figure  20) . A few patients with leukemia present with pericardial effusion, which is usually hemorrhagic. Large calcific deposits in the right side of the heart have been reported (85) . Leukemic cells have even caused obstruction of coronary arteries containing atherosclerotic plaques (Figure 21) .
Lymphoma also has a very high frequency of metastases to the heart (8, (86) (87) (88) . Nearly 25% of patients with lymphomas of various types have involvement of the epicardium, myocardium, endocardium, or some combination. In contrast to leukemic involvement, the lymphomatous deposits are usually grossly discernible (Figure 22) . Some cancers, like osteogenic sarcoma, may have calcium within them (89) (90) (91) (Figure 23 ). Others may not (Figure 24) . Adenocarcinoma of the colon may also nearly obliterate the right ventricular cavity (Figure 25 ). Some sarcomas may involve the wall Figure 22 . Lymphoma of the heart. This 38-year-old man with AIDS developed complete heart block and a large hemorrhagic pericardial effusion. A large tumor resided within the right atrial cavity, and multiple tumor deposits (white in color) were present in the right atrioventricular sulcus, atrial septum, ventricular septum (cephalad portion), and left ventricular free wall. of all chambers as well as being located within 1 or more cavities and in the epicardium (Figure 26) . Others may obstruct a valve orifice (Figure 27 ).
NONNEOPLASTIC CONDITIONS FREQUENTLY MISTAKEN FOR CARDIAC NEOPLASM Pericardial cyst
Pericardial or mesothelial cysts are the most frequent benign "tumors" of the pericardium. These cysts are generally asymptomatic and found on "routine" chest radiograph (92) (Figure 28) . About a quarter of the patients, however, develop various symp- . Sarcoma metastatic to the heart. This 30-year-old woman was found to have complete heart block and widespread metastatic cancer shortly before dying suddenly. The site of the primary tumor was never determined, but histologically the tumor was an undifferentiated sarcoma. (a) View of the heart showing numerous tumor deposits on the epicardial surface and over the aorta and pulmonary trunk. toms, including chest pain, dyspnea, cough, and tachycardia, as a consequence of a pericardial cyst. The cysts are usually outside the pericardial cavity and, therefore, really should not be considered cardiac tumors.
Teratoma
Teratomas are extracardiac in at least 99% of cases but are still within the pericardial cavity (93) (94) (95) (Figure 29) . They arise and receive their blood supply from the ascending aorta or pulmonary trunk, presumably through the vasa vasorum. Most are found in infants and children, primarily in females. Recurrent serous pericardial effusion in children should suggest intrapericardial teratoma. Because these tumors may become quite large, they may compress various cardiac chambers and therefore produce symptoms.
Lipomatous hypertrophy of the atrial septum
Massive fatty infiltration of the atrial septum is an extremely common condition occurring almost exclusively in persons >50 years of age and usually in individuals >65 years of age (96) (Figure 30) . These lesions are essentially limited to obese people, and they are always associated with enormous quantities of subepicardial adipose tissue, particularly in the atrioventricular sulci. These hearts are almost always so fat that they float in water (97) . Normally, the atrial septum is <1 cm in thickness. In patients with lipomatous hypertrophy of the atrial septum, the atrial septum cephalad to the fossa ovale may be as thick as 7 cm, and the atrial septum caudal to the fossa ovale may be as thick as 4 cm. Extensive infiltration of fat into the atrial septum may be associated with atrial arrhythmias. These patients should not be operated on to remove fat from the atrial septum. The treatment is simply weight loss. The fatty deposits may be diagnosed by echocardiography, CT, or MRI (98, 99) . Fat in the subepicardial adipose tissue has been confused with pericardial effusion on echocardiogram (100).
Papillary fibroelastomas
Papillary fibroelastomas are small avascular growths with multiple papillary fronds usually limited to cardiac valves, mainly the aortic and mitral; they are common in older persons (101) (Figure 31 ). They consist of fibrous tissue covered by an elastic membrane, which in turn is covered by endocardium. In about 15% of patients, they also occur on left ventricular or ventricular septal mural endocardium (102) (103) (104) (105) (106) (107) (108) (109) (110) (111) , particularly in patients with small or relatively small ventricular cavities, such as in patients with hypertrophic cardiomyopathy (102, 108) or mitral stenosis with or without aortic valve stenosis (106, 109, 110) . When located on the aortic valve, papillary fibroelastomas are usually found on the ventricular aspects of the cusps in the more central portions. They also occur on the aortic aspects of these cusps, usually near the margins (112) (113) (114) (115) . On the mitral valve leaflets, they are usually on the atrial aspects near the margins (116) (117) (118) (119) (120) (121) (122) (123) . In patients with hypertrophic cardiomyopathy or mitral stenosis, they may be on the ventricular aspects of the anterior mitral leaflet and sometimes on mural endocardium, particularly over the papillary muscles. These lesions may be the result of contact of one valve leaflet with another or one mural endocardial surface with another.
A number of cases of papillary fibroelastomas and stroke have been reported (114-117, 121, 122, 124-128) . Whether the stroke was truly connected with the cardiac fibroelastomas is debatable. Some patients have been in their 20s or 30s without other predisposing features or findings commonly associated with cerebral infarction, and the occurrence of stroke in the younger age group is suggestive of a connection. In contrast to myxoma, tissue from which has been seen in systemic emboli, papillary fibroelastomas have not been observed by histologic studies in a cerebral artery of any patient with cardiac papillary fibroelastomas who had a stroke. Furthermore, the papillary fibroelastomas are firmly attached to valvular or mural endocardium, and dislodgment of a fibroelastoma therefore would appear unlikely. Thrombus, however, is occasionally superimposed on papillary fibroelastomas, and thrombus may be the material that is dislodged and is responsible for the stroke.
Angina pectoris (128) , acute myocardial infarction (129) (130) (131) (132) (133) , and sudden death (129, 134) have been observed in pa- tients with cardiac papillary fibroelastomas, mainly on the aortic valve. These papillary growths may obstruct an aortic ostium of a coronary artery (135, 136) . On rare occasions, papillary fibroelastomas have been observed on the right side of the heart, mainly on the tricuspid valve (137) (138) (139) (140) .
Papillary fibroelastomas have been operatively excised from the cardiac valve and/or mural endocardium in patients with evidence of stroke or other peripheral events, and a few patients have had cardiac valve replacement (106, 108, 110, 111, 114, 115, 117-119, 124, 125, 132, 136, 138, 140) . When papillary fibroelastomas are detected by echocardiography in asymptomatic patients, operative excision rarely appears warranted. 
Thrombi
Thrombi within an intracardiac cavity may be indistinguishable from neoplasm by echocardiogram or radiograph. Grossly, however, they are very different.
Thyroid gland
Aberrant thyroid tissue may be located with the pericardial sac (141) (Figure 32 ).
Calcium
Calcium deposits may occur within any cardiac cavity, and some may be large (85, 142) .
Abscess
Large abscesses, mainly of fungal origin, may replace portions of cardiac wall, protrude from the endocardial surfaces (mural endocarditis), and potentially obstruct inflow into or outflow from a cardiac chamber (143) . Figure 33 shows mucormycosis obstructing a pulmonary vein and occupying a portion of the left atrial cavity. These abscesses are especially common after unsuccessful bone marrow transplantation (Figure 34 ).
Sarcoid
When located in myocardium, sarcoid granuloma may grossly resemble neoplasm (144) (145) (146) (Figure 35 ).
CONSEQUENCES OF THERAPY FOR NEOPLASMS IN THE HEART Radiation heart disease
Radiation heart disease was first recognized after radiation therapy for Hodgkin's disease (147) (148) (149) (150) . Some of the earlier patients with Hodgkin's disease received >8000 rads, which adversely affected the pericardium, myocardium, and endocardium. The most common manifestation of radiation heart disease is pericardial effusion (Figure 36 ). Fibrin deposits occur on both the visceral and parietal aspects of the pericardia. Because coronary arteries are located in subepicardial adipose tissue, they often receive the effects of radiation. Many patients, particularly patients with Hodgkin's disease, have been reported to have coro- Figure 36 . Radiation heart disease for Hodgkin's disease. This 26-year-old man was found to have Hodgkin's disease 27 months earlier by biopsy of a painless nodule in the neck. He received about 13,000 rads to the neck and mediastinum. He died from pericardial tamponade. Shown here is a radiograph with air in the pericardial sac. Both the parietal and visceral pericardia were thickened, and a large pericardial effusion was present. Reprinted from Roberts WC, Glancy DL, DeVita VT Jr. Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides). A study of 196 autopsy cases. Am J Cardiol 1968;22:85-107 with permission from Excerpta Medica Inc.
nary arterial narrowing at a very young age after radiation therapy. The intimal plaques resulting from radiation heart disease cannot be distinguished from plaques occurring from typical atherosclerosis. The distinguishing feature of radiation heart disease involving the coronary arteries is extensive fibrous thickening of the adventitia, as well as loss, focally or diffusely, of internal and external elastic membranes, particularly the latter (Figure 37 ). Narrowing of coronary ostia also is common in radiation heart disease (150) . In addition, radiation can cause considerable scarring within the subepicardial adipose tissue. The second most common manifestation of radiation heart disease is mural endocardial thickening, most commonly of the right atrium and ventricle, but focally also in the left ventricle. Its third most common manifestation is interstitial fibrosis; its location depends on the portal of entry, but it involves the anterior wall of the right ventricle more than any other portion of the heart (Figure 37 ). Radiation in excess also can cause focal thickening of valves (Figure 38 ).
Cardiac hemorrhages
Thrombocytopenia, particularly if persistent, often results in focal epicardial, myocardial, and mural endocardial hemorrhages. If the hemorrhages are located in conduction tissue, various degrees of heart block or arrhythmias may be the consequence.
Cardiac infection
The most common cardiac infections today in cancer patients are myocardial abscesses and mural endocardial and epicardial abscesses. These are particularly prevalent in patients with prolonged leukopenia (143, 151, 152) . Patients having unsuccessful bone marrow transplants are particularly prone to these infections, which usually are produced by fungi, not bacteria. Gas gangrene may involve the heart as well as most other body organs and tissues (153) .
Cardiac adiposity or the corticosteroid-treated heart
Patients with various types of cancers, particularly leukemia or lymphoma, and those developing cancer after organ transplan- Figure 38 . Radiation heart disease. Shown here is a focally thickened anterior mitral leaflet in a 30-year-old man who received approximately 11,000 rads to the mediastinum 5 years earlier for Hodgkin's disease. Although there was no valve dysfunction, the amount of focal leaflet scarring was abnormal for a 30-year-old man and suggested that this unusual leaflet scarring was a consequence of the earlier radiation. Reprinted from Brosius FC III, Waller BF, Roberts WC. Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med 1981;70:519-530 with permission from Excerpta Medica Inc. Figure 37 . Radiation heart disease. On routine chest radiograph at age 24, this 33-year-old man was found to have bilateral hilar masses, and histologic examination of one of the hilar nodes disclosed Hodgkin's disease. He received approximately 8000 rads to his mediastinum, 5000 from an anterior portal. Thereafter, he was asymptomatic until 2 1 /2 hours before death when he developed severe tation usually receive corticosteroid therapy for prolonged periods. The consequence is excessive deposition of fat in the heart, mainly in the subepicardial areas (154) . These hearts may become so fatty that they float in water (buffalo hump of the heart), and this excessive subepicardial adipose tissue may simulate pericardial effusion (97, 100) .
Cardiac hemosiderosis
Normally the human body contains approximately 4 g of iron. If the iron level increases to about 25 g, iron deposits are usually found within myocardial cells. Patients who receive 100 units of blood without associated bleeding diatheses can acquire approximately 25 g of iron within the body organs and tissues. This situation may exist in some patients with cancer, particularly leukemia, and the result is cardiac hemosiderosis (155) . These patients may be asymptomatic or may develop features of dilated cardiomyopathy with heart failure. At times, ventricular arrhythmias may be a consequence. Myocardial restriction as a result of myocardial iron deposits has occurred, but dilation is far more common (156) .
Anthracycline chemotherapy (doxorubicin and daunorubicin)
Cardiac toxicity is a well-recognized complication of doxorubicin and daunorubicin and is frequently the dose-limiting factor in their administration (157) (158) (159) . Clinical toxicity is usually manifested by evidence of impaired left ventricular systolic function. Morphologic signs of toxicity may be present when clinical signs of toxicity are absent. 
